A Balanced View of Efficacy and Safety of Aspirin in Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|35|5101-5107

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.35, 2015-10, pp. : 5101-5107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of aspirin in cardiovascular diseases – forgotten benefits?

By Williams Adam   Hennekens Charles H  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 109-115

Informa Healthcare

Access to resources Recommend Favorite

The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease

By Cooke Glen E   Goldschmidt-Clermont Pascal J  

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 815-826

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of tamsulosin in the treatment of urological diseases

By Michel Martin C   de la Rosette Jean JMCH  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 151-160

Informa Healthcare

Access to resources Recommend Favorite

Heterogeneity of Efficacy and Safety of Antiplatelet Therapy in Cardiovascular and Cerebrovascular Disease

By Gebel James M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 115-124

Adis International

Access to resources Recommend Favorite

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness

By Ho Wai Khoon   Hankey Graeme J   Eikelboom John W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 493-503

Informa Healthcare

Access to resources Recommend Favorite